Funder: ALS Association
Due Dates: November 18, 2025 (Letter of Intent) | February 17, 2026 (Full proposal, by invitation only)
Funding Amounts: Up to $1,000,000 total over 2–3 years per award; indirect costs limited to 10% of direct costs.
Summary: Supports early-stage clinical trials and imaging tracer studies to accelerate new ALS therapies from lab discovery to patient treatment.
Key Information: Full proposals are by invitation only; both academic and industry applicants are eligible.